Apyx Medical Corporation
APYX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $56 | $91 | $81 | $440 |
| - Cash | $32 | $44 | $10 | $31 |
| + Debt | $39 | $39 | $1 | $0 |
| Enterprise Value | $63 | $86 | $71 | $410 |
| Revenue | $48 | $52 | $45 | $49 |
| % Growth | -8.1% | 17.6% | -8.3% | – |
| Gross Profit | $29 | $34 | $29 | $34 |
| % Margin | 61% | 64.5% | 65.4% | 69.3% |
| EBITDA | -$17 | -$18 | -$22 | -$14 |
| % Margin | -34.9% | -34.6% | -49.4% | -28.7% |
| Net Income | -$23 | -$19 | -$23 | -$15 |
| % Margin | -48.8% | -35.7% | -52.1% | -31.3% |
| EPS Diluted | -0.66 | -0.54 | -0.67 | -0.44 |
| % Growth | -22.2% | 19.4% | -52.3% | – |
| Operating Cash Flow | -$18 | -$5 | -$20 | -$10 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$19 | -$6 | -$21 | -$11 |